Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,400 Cr
down ₹116 Cr vs May 2022
- Stocks held
- 27
- unchanged
- Top 10 weight
- 70.5%
- of the portfolio in its ten largest
- Cash & debt
- 1.0%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 8, trimmed 19
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In June 2022 it disclosed 27 stocks worth ₹4,400 Cr, down ₹116 Cr from May 2022. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), Cipla Limited (8.3%), Dr. Reddy's Laboratories Limited (8.0%); the ten largest together made up 70.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 80.3% of its equity. Cash and debt stood at 1.0%. Compared with May 2022 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
13%
Holds more cash than 13% of peers
Holdings in June 2022
Download CSVEvery line the fund disclosed, with the change against May 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.78%
- Δ weight
- down 0.13 pts
- Value
- ₹606 Cr
- Δ value
- down ₹21.9 Cr
- Status
- Trimmed
- Weight
- 8.34%
- Δ weight
- down 0.90 pts
- Value
- ₹367 Cr
- Δ value
- down ₹50.2 Cr
- Status
- Trimmed
- Weight
- 7.99%
- Δ weight
- up 0.25 pts
- Value
- ₹352 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 7.43%
- Δ weight
- up 0.54 pts
- Value
- ₹327 Cr
- Δ value
- up ₹15.7 Cr
- Status
- Added
- Weight
- 6.87%
- Δ weight
- up 0.24 pts
- Value
- ₹303 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 6.37%
- Δ weight
- up 0.51 pts
- Value
- ₹280 Cr
- Δ value
- up ₹15.5 Cr
- Status
- Added
- Weight
- 5.97%
- Δ weight
- up 0.08 pts
- Value
- ₹263 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 5.95%
- Δ weight
- down 0.05 pts
- Value
- ₹262 Cr
- Δ value
- down ₹9.2 Cr
- Status
- Trimmed
- Weight
- 4.08%
- Δ weight
- down 0.03 pts
- Value
- ₹180 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 3.73%
- Δ weight
- up 0.13 pts
- Value
- ₹164 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 3.37%
- Δ weight
- down 0.12 pts
- Value
- ₹148 Cr
- Δ value
- down ₹9.3 Cr
- Status
- Trimmed
- Weight
- 3.07%
- Δ weight
- down 0.10 pts
- Value
- ₹135 Cr
- Δ value
- down ₹8 Cr
- Status
- Trimmed
- Weight
- 3.03%
- Δ weight
- down 0.02 pts
- Value
- ₹133 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 2.52%
- Δ weight
- down 0.13 pts
- Value
- ₹111 Cr
- Δ value
- down ₹8.9 Cr
- Status
- Trimmed
- Weight
- 2.49%
- Δ weight
- down 0.09 pts
- Value
- ₹110 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- Weight
- 2.49%
- Δ weight
- down 0.07 pts
- Value
- ₹109 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 2.03%
- Δ weight
- down 0.07 pts
- Value
- ₹89.3 Cr
- Δ value
- down ₹5.3 Cr
- Status
- Trimmed
- Weight
- 1.92%
- Δ weight
- up 0.44 pts
- Value
- ₹84.7 Cr
- Δ value
- up ₹17.8 Cr
- Status
- Added
- Weight
- 1.72%
- Δ weight
- down 0.05 pts
- Value
- ₹75.6 Cr
- Δ value
- down ₹4.2 Cr
- Status
- Trimmed
- Weight
- 1.40%
- Δ weight
- down 0.03 pts
- Value
- ₹61.6 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 1.02%
- Δ weight
- up 0.30 pts
- Value
- ₹45 Cr
- Δ value
- up ₹12.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.01%
- Δ weight
- down 0.65 pts
- Value
- ₹44.5 Cr
- Δ value
- down ₹30.7 Cr
- Status
- Trimmed
- Weight
- 0.76%
- Δ weight
- down 0.03 pts
- Value
- ₹33.4 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.65%
- Δ weight
- down 0.04 pts
- Value
- ₹28.4 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 0.64%
- Δ weight
- up 0.06 pts
- Value
- ₹28.1 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 0.62%
- Δ weight
- up 0.01 pts
- Value
- ₹27.1 Cr
- Δ value
- down ₹39 L
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- down 0.04 pts
- Value
- ₹18.9 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.33%
- Δ weight
- up 0.01 pts
- Value
- ₹14.4 Cr
- Δ value
- down ₹14 L
- Status
- Trimmed
What changed, May 2022 to Jun 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Alkem Laboratories Limitedup ₹17.8 Cr (+0.44% pts)
- Divi's Laboratories Limitedup ₹15.7 Cr (+0.54% pts)
- Abbott India Limitedup ₹15.5 Cr (+0.51% pts)
- IPCA Laboratories Limitedup ₹12.2 Cr (+0.30% pts)
- Torrent Pharmaceuticals Limited ₹2.9 Cr (+0.24% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2022, the weight rose most in Pharmaceuticals & Biotechnology (+0.4 pts), and fell most in Healthcare Services (−0.3 pts).
- Pharmaceuticals & Biotechnology79.9% → 80.3%+0.4 pts
- Healthcare Services17.7% → 17.4%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2021 | Dec 2021 | Mar 2022 | May 2022 | Jun 2022 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.3% | 76.5% | 76.8% | 79.9% | 80.3% |
| Healthcare Services | 20.6% | 21.0% | 20.8% | 17.7% | 17.4% |
| Pharmaceuticals | 2.3% | 2.0% | 1.8% | 1.8% | 1.7% |
| Healthcare Equipment & Supplies | — | 0.5% | 0.6% | 0.6% | 0.6% |
Allocation in Jun 2022change vs May 2022
- Pharmaceuticals & Biotechnology (18)80.3%▲ 0.4 pts
- Healthcare Services (7)17.4%▼ 0.3 pts
- Pharmaceuticals (1)1.7%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jun 2022
1.0%
▼ 0.7 pts vs May 2022
- Cash alone
- 1.0%
- cash and net receivables
- A year earlier
- 0.7%
- Jun 2021 · now ▲ 0.3 pts
- Last 12 months
- 0.4% – 4.8%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.